 |
Implitapide |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with Fredrickson type I or V hyperlipoproteinemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-08-19 00:00:00 |
| Sponsor | Medical Research Laboratories International;2 Tesseneer Drive;Highland Heights, Kentucky, 41076 |
